J.Safra Asset Management Corp Legend Biotech Corp Transaction History
J.Safra Asset Management Corp
- $1.31 Billion
- Q2 2025
A detailed history of J.Safra Asset Management Corp transactions in Legend Biotech Corp stock. As of the latest transaction made, J.Safra Asset Management Corp holds 31 shares of LEGN stock, worth $1,286. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 28
10.71%
Holding current value
$1,286
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
230Shares Held
73.6MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$287 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$279 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$248 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$237 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$156 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.95B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...